Brent S. Abel

1.1k total citations
36 papers, 759 citations indexed

About

Brent S. Abel is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Brent S. Abel has authored 36 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Brent S. Abel's work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Brent S. Abel is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). Brent S. Abel collaborates with scholars based in United States, Germany and Greece. Brent S. Abel's co-authors include Monica C. Skarulis, Ranganath Muniyappa, Lynnette K. Nieman, Nicola M. Neary, Mary Walter, Christine C. Krieger, George J. Kahaly, Marvin C. Gershengorn, Bernice Marcus‐Samuels and Rebecca J. Brown and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Brent S. Abel

33 papers receiving 746 citations

Peers

Brent S. Abel
Sung‐Kil Lim South Korea
Anne Gill United States
Tal Oron Israel
Andrew Whatmore United Kingdom
Sung‐Kil Lim South Korea
Brent S. Abel
Citations per year, relative to Brent S. Abel Brent S. Abel (= 1×) peers Sung‐Kil Lim

Countries citing papers authored by Brent S. Abel

Since Specialization
Citations

This map shows the geographic impact of Brent S. Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent S. Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent S. Abel more than expected).

Fields of papers citing papers by Brent S. Abel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent S. Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent S. Abel. The network helps show where Brent S. Abel may publish in the future.

Co-authorship network of co-authors of Brent S. Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Brent S. Abel. A scholar is included among the top collaborators of Brent S. Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent S. Abel. Brent S. Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wing, Allison, et al.. (2025). Serum Proteomics of Insulin Resistance Disorders Distinguish MASLD From Lipodystrophy and Insulin Receptor Defects. The Journal of Clinical Endocrinology & Metabolism. 111(4). 1057–1065.
2.
Kushchayeva, Yevgeniya, Vasyl Vasko, Kirk Jensen, et al.. (2025). Differentiated Thyroid Cancer in Severe Insulin Resistance. PubMed. 12(4). 229–240. 1 indexed citations
3.
Lightbourne, Marissa, Brent S. Abel, Mary Walter, et al.. (2023). Insulin Signaling Through the Insulin Receptor Increases Linear Growth Through Effects on Bone and the GH–IGF-1 Axis. The Journal of Clinical Endocrinology & Metabolism. 109(1). e96–e106. 11 indexed citations
4.
Bahn, Young Jae, Hariom Yadav, Paolo Piaggi, et al.. (2023). CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism. Journal of Clinical Investigation. 133(13). 5 indexed citations
5.
Haykal, Romanos, Brent S. Abel, Marissa Lightbourne, et al.. (2023). THU268 Hyperuricemia In Insulin Resistance Is Associated With Increased Synthesis And Not Decreased Renal Excretion Of Uric Acid In Humans. Journal of the Endocrine Society. 7(Supplement_1). 2 indexed citations
6.
Abel, Brent S., et al.. (2023). FRI056 Effect Of 48 Hour Of Metreleptin In Humans With Lipodystrophy During Controlled Feeding. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations
7.
Abel, Brent S., et al.. (2021). Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome. Journal of the Endocrine Society. 5(8). bvab109–bvab109. 16 indexed citations
8.
Lightbourne, Marissa, Anna Wolska, Brent S. Abel, et al.. (2020). Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin. Journal of the Endocrine Society. 5(2). bvaa191–bvaa191. 6 indexed citations
9.
Shekhar, Skand, Ninet Sinaii, Jorge A. Irizarry‐Caro, et al.. (2020). Prevalence of Hypothyroidism in Patients With Erdheim-Chester Disease. JAMA Network Open. 3(10). e2019169–e2019169. 3 indexed citations
10.
Pydi, Sai P., Shanu Jain, Wesley Tung, et al.. (2019). Adipocyte β-arrestin-2 is essential for maintaining whole body glucose and energy homeostasis. Nature Communications. 10(1). 2936–2936. 43 indexed citations
11.
12.
Muniyappa, Ranganath, Shannon D. Sullivan, Sri Harsha Tella, et al.. (2017). Effects of growth hormone administration on luteinizing hormone secretion in healthy older men and women. Physiological Reports. 5(23). 3 indexed citations
13.
Muniyappa, Ranganath, Brent S. Abel, Mary Walter, et al.. (2017). Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy. Journal of clinical lipidology. 11(2). 543–550. 21 indexed citations
14.
Krieger, Christine C., Robert F. Place, Bernice Marcus‐Samuels, et al.. (2016). TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis. The Journal of Clinical Endocrinology & Metabolism. 101(6). 2340–2347. 114 indexed citations
15.
Muniyappa, Ranganath, Amy E. Levenson, Mary Walter, et al.. (2016). Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy. The Journal of Clinical Endocrinology & Metabolism. 101(4). 1790–1797. 9 indexed citations
16.
Gounden, Verena, Jianghong Gu, Brent S. Abel, et al.. (2015). An improved micro-method for the measurement of steroid profiles by APPI-LC–MS/MS and its use in assessing diurnal effects on steroid concentrations and optimizing the diagnosis and treatment of adrenal insufficiency and CAH. The Journal of Steroid Biochemistry and Molecular Biology. 162. 110–116. 28 indexed citations
17.
Abraham, Smita Baid, Brent S. Abel, Robert Wesley, et al.. (2015). Cosyntropin-Stimulated Serum Free Cortisol in Healthy, Adrenally Insufficient, and Mildly Cirrhotic Populations. The Journal of Clinical Endocrinology & Metabolism. 101(3). 1075–1081. 16 indexed citations
18.
Abel, Brent S., Natalie D. Shaw, Jenifer M. Brown, et al.. (2013). Responsiveness to a Physiological Regimen of GnRH Therapy and Relation to Genotype in Women With Isolated Hypogonadotropic Hypogonadism. The Journal of Clinical Endocrinology & Metabolism. 98(2). E206–E216. 17 indexed citations
19.
Neary, Nicola M., Ariel López-Chávez, Brent S. Abel, et al.. (2012). Neuroendocrine ACTH-Producing Tumor of the Thymus—Experience with 12 Patients over 25 Years. The Journal of Clinical Endocrinology & Metabolism. 97(7). 2223–2230. 49 indexed citations
20.
Nader, Nader D., Sinnie Sin Man Ng, Yonghong Wang, et al.. (2012). Liver X Receptors Regulate the Transcriptional Activity of the Glucocorticoid Receptor: Implications for the Carbohydrate Metabolism. PLoS ONE. 7(3). e26751–e26751. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026